France

France is a powerhouse of global life sciences innovation, bolstered by the ambitious France 2030 investment plan that funnels billions into biomanufacturing and breakthrough medical research.

The nation is best known for its world-class pharmaceutical industry, home to global giants like Sanofi and a rapidly growing cluster of biotechnology startups specializing in immuno-oncology, gene therapy and rare diseases.

France's medical device (medtech) sector is equally dynamic, leading the way in robotic surgery and AI-driven diagnostics while benefiting from a sophisticated regulatory environment.

As a pioneer in healthcare innovation, the country is a frontrunner in digital health, integrating generative AI into drug discovery and hospital management systems to enhance patient outcomes.

Its academic foundation is anchored by prestigious institutions like Inserm and the Institut Pasteur, which consistently produce high-impact clinical research and top-tier scientific talent.

Strategic bio-clusters in Paris-Saclay and Lyon provide a collaborative infrastructure where academic research and private enterprise converge to accelerate the commercialization of new therapies.

France's attractiveness to international investors is further strengthened by the Research Tax Credit (CIR), one of the most generous R&D incentives in Europe.

With a focus on reindustrialization, the ecosystem is currently experiencing a manufacturing boom, aiming to become the European leader in biotherapy production.

This unique blend of cutting-edge technology and state-backed incentives makes France a premier destination for life sciences investment and global partnerships.